Stockwire
• Wealth Insight - May 2025
Analyst's Diary: Who's making your medicine?
The different drug development stages and the companies behind them
01-May-2025•Abhinav Goel
Top Picks
What Small Caps Actually Pay You For
12 min read•By Ruchira Sharma
Welcome to the New Value Research!
2 min read•By Value Research
New episodes every Friday
Buying the fund house
Judging listed fund houses by the metric that matters most
Other Episodes
-
Growth that goes nowhere
Why every growing company isn't making its shareholders richer
-
A fall is not a loss
A red number on your screen is not a loss. You make it permanent only by acting on it.
-
The question you didn't ask
Why the best investors check lists, not just conviction
-
The AI bubble question
Whether AI is a bubble matters less than whether you are behaving like one
More stories from Wealth Insight May 2025
Explore the edition
When markets fall, look within
3 min read•By Dhirendra Kumar
5 traps turning your portfolio red
13 min read•By Udhayaprakash
5 min read•By Value Research Team
'Diversification helps during volatile times'
10 min read•By Value Research Team
Market Reporter: Who made the news?
1 min read•By Value Research Team
1 min read•By Value Research Team
Market Barometer: The metrics that matter
1 min read•By Value Research Team
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
